secwatch.observer — SEC 8-K summary
======================================

Issuer:     VERACYTE, INC. (VCYT)
CIK:        0001384101
Form:       8-K
Filed at:   2021-07-12T23:59:59+00:00
Accession:  0001384101-21-000118
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Veracyte appoints Rebecca Chambers as CFO effective July 19, 2021
-----------------------------------------------------------------

- Rebecca Chambers, 43, appointed CFO effective July 19, 2021; previously CFO of Outset Medical.
- Jane Alley resigns as acting CFO (same date) but remains VP, Corporate Controller and PAO.
- Chambers gets $450K salary, $100K sign-on bonus, 67,000 stock options, 34,000 RSUs, and up to 13,600 performance-based RSUs.
- Severance: 50% base salary for non-CIC termination; 150% plus full equity vesting for change-of-control termination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1384101/000138410121000118/0001384101-21-000118-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1384101/000138410121000118/vcyt-20210712.htm
  HTML page:      https://secwatch.observer/filing/0001384101-21-000118

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer